Evaluation of Poly(<i>N</i>-Ethyl Pyrrolidine Methacrylamide) (EPA) and Derivatives as Polymeric Vehicles for miRNA Delivery to Neural Cells
Altea Soto,
Manuel Nieto-Díaz,
Enrique Martínez-Campos,
Ana Noalles-Dols,
María Asunción Barreda-Manso,
Felipe Reviriego,
Helmut Reinecke,
David Reigada,
Teresa Muñoz-Galdeano,
Irene Novillo,
Alberto Gallardo,
Juan Rodríguez-Hernández,
Ramón Eritja,
Anna Aviñó,
Carlos Elvira,
Rodrigo M. Maza
Affiliations
Altea Soto
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Manuel Nieto-Díaz
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Enrique Martínez-Campos
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
Ana Noalles-Dols
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
María Asunción Barreda-Manso
Functional Exploration and Neuromodulation of the Central Nervous System Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Felipe Reviriego
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
Helmut Reinecke
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
David Reigada
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Teresa Muñoz-Galdeano
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Irene Novillo
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
Alberto Gallardo
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
Juan Rodríguez-Hernández
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
Ramón Eritja
Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain
Anna Aviñó
Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain
Carlos Elvira
Polymer Functionalization Group, Instituto de Ciencia y Tecnología de Polímeros-Consejo Superior de Investigaciones Científicas (ICTP-CSIC), Departamento de Química Macromolecular Aplicada, Juan de la Cierva 3, 28006 Madrid, Spain
Rodrigo M. Maza
Molecular Neuroprotection Group, Hospital Nacional de Parapléjicos (SESCAM), 45071 Toledo, Spain
MicroRNAs (miRNAs) are endogenous, short RNA oligonucleotides that regulate the expression of hundreds of proteins to control cells’ function in physiological and pathological conditions. miRNA therapeutics are highly specific, reducing the toxicity associated with off-target effects, and require low doses to achieve therapeutic effects. Despite their potential, applying miRNA-based therapies is limited by difficulties in delivery due to their poor stability, fast clearance, poor efficiency, and off-target effects. To overcome these challenges, polymeric vehicles have attracted a lot of attention due to their ease of production with low costs, large payload, safety profiles, and minimal induction of the immune response. Poly(N-ethyl pyrrolidine methacrylamide) (EPA) copolymers have shown optimal DNA transfection efficiencies in fibroblasts. The present study aims to evaluate the potential of EPA polymers as miRNA carriers for neural cell lines and primary neuron cultures when they are copolymerized with different compounds. To achieve this aim, we synthesized and characterized different copolymers and evaluated their miRNA condensation ability, size, charge, cytotoxicity, cell binding and internalization ability, and endosomal escape capacity. Finally, we evaluated their miRNA transfection capability and efficacy in Neuro-2a cells and rat primary hippocampal neurons. The results indicate that EPA and its copolymers, incorporating β-cyclodextrins with or without polyethylene glycol acrylate derivatives, can be promising vehicles for miRNA administration to neural cells when all experiments on Neuro-2a cells and primary hippocampal neurons are considered together.